Center for Cancer Immunotherapy and Immunobiology

Design for Science
CCII’s new home, the Bristol Myers Squibb Building at the Center for Cancer Immunotherapy and Immunobiology at the Kyoto University campus, has been made possible by funding from the Japanese government and a generous donation from pharmaceutical giant Bristol Myers Squibb. In addition, Tadao Ando, one of Japan’s foremost contemporary architects, provided invaluable support by supervising the grand design of the building’s exterior and interior.

Presently, lab facilities and offices of the Center for Cancer Immunotherapy and Immunobiology (CCII) are spread out over several buildings within the Kyoto University Graduate School of Medicine, with main offices and laboratories at Kyoto University’s “Medical Innovation Center”. In 2024, we plan to move into a brand-new building across the street of the Kyoto University hospital.
With a total floorspace of 9500 m2 over 5 floors, the new building will provide laboratory and office space for up to 300 scientists, research fellows, students, or visitors and additional room for shared facilities and special instrumentation, including a dedicated animal facility in the basement. The first floor of the building will host a multi-functional hall for conferences and cultural events, space for exhibitions and educational activities, and a cafeteria.

more

WordPress Lightbox